Palomino Laboratories Inc.
PALX
$15.32
-$0.08-0.52%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 106.46% | 4,424.72% | 18,465.00% | 133,641.67% | 84,250.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 304.65% | 6,886.52% | 18,465.00% | 133,641.67% | 84,250.00% |
| Operating Income | -304.65% | -6,886.52% | -18,465.00% | -133,641.67% | -84,250.00% |
| Income Before Tax | -450.54% | -26.21% | -7,326.00% | -28,865.08% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -450.54% | -26.21% | -7,326.00% | -28,865.08% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -450.54% | -26.21% | -7,326.00% | -28,865.08% | -- |
| EBIT | -304.65% | -6,886.52% | -18,465.00% | -133,641.67% | -84,250.00% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -141.54% | 84.82% | -680.39% | -14,092.11% | -- |
| Normalized Basic EPS | -141.51% | 84.82% | -678.13% | -13,941.67% | -- |
| EPS Diluted | -141.54% | 84.82% | -680.39% | -14,092.11% | -- |
| Normalized Diluted EPS | -141.51% | 84.82% | -678.13% | -13,941.67% | -- |
| Average Basic Shares Outstanding | 744.34% | 732.02% | 857.08% | 103.60% | 56.19% |
| Average Diluted Shares Outstanding | 744.34% | 732.02% | 857.08% | 103.60% | -56.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |